Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ProPhase Labs's annualizedGross Profit for the quarter that ended in Dec. 2023 was $-12.22 Mil.
ProPhase Labs's average Total Assets over the quarter that ended in Dec. 2023 was $91.82 Mil. Therefore, ProPhase Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was -13.31%.
ProPhase Labs Gross-Profit-to-Asset % Historical Data
The historical data trend for ProPhase Labs's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ProPhase Labs's Gross-Profit-to-Asset %
For the Diagnostics & Research subindustry, ProPhase Labs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProPhase Labs's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where ProPhase Labs's Gross-Profit-to-Asset % falls into.
ProPhase Labs Gross-Profit-to-Asset % Calculation
ProPhase Labs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
ProPhase Labs Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of ProPhase Labs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
ProPhase Labs (ProPhase Labs) Business Description
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRPH has been successfully added to your 